Cargando…
Wells’ syndrome possibly caused by hematologic malignancy, influenza vaccination or ibrutinib: A case report
BACKGROUND: Wells’ syndrome (eosinophilic cellulitis) is an uncommon eosinophilic dermatosis of uncertain pathogenesis, characterized by clinical polymorphism and suggestive but nonspecific histopathologic traits. Its course is recurrent, and response to therapy is unpredictable. In a case in which...
Autores principales: | Šajn, Mihela, Luzar, Boštjan, Zver, Samo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631159/ https://www.ncbi.nlm.nih.gov/pubmed/36338211 http://dx.doi.org/10.12998/wjcc.v10.i30.10997 |
Ejemplares similares
-
Acquired haemophilia in patients with malignant disease: A case report
por: Krašek, Veronika, et al.
Publicado: (2021) -
Ibrutinib for B cell malignancies
por: Novero, Aileen, et al.
Publicado: (2014) -
288. Hepatitis B Virus Reactivation in Patients with Hematologic Malignancies after Anticancer Therapy Which Included Ibrutinib
por: Malek, Alexandre, et al.
Publicado: (2019) -
1092. Increased Risk of Serious Infections in Mantle Cell Lymphoma Versus Other Hematologic Malignancies in Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020) -
Long term follow-up report of cardiac toxicity in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
por: Kozelj, Mirta, et al.
Publicado: (2013)